5% Off
Depo-pred40 mg/ml
Ziska Pharmaceuticals Ltd.
৳71.25
Add to cart
Generic medicine
Methyl Prednisolone Acetate: Brands, Price & Uses in Bangladesh
Indications of Methyl Prednisolone Acetate Methyl Prednisolone Acetate is a long-acting (depot) corticosteroid suspension used by injection.
About Methyl Prednisolone Acetate
Indications of Methyl Prednisolone Acetate
Indications of Methyl Prednisolone Acetate
Methyl Prednisolone Acetate is a long-acting (depot) corticosteroid suspension used by injection. Its indications are classified below by the route of injection and strength of clinical evidence.
Established/Approved Uses
- Intra-articular or soft-tissue injection: Adjunctive short-term therapy for acute flares of osteoarthritis, rheumatoid arthritis, acute gouty arthritis, bursitis, tenosynovitis, and epicondylitis, when localized anti-inflammatory effect is desired.
- Intralesional injection: Keloids, localized hypertrophic and inflammatory lesions of lichen planus, psoriatic plaques, alopecia areata, and discoid lupus erythematosus.
- Intramuscular (systemic) injection: Used as a long-acting alternative to oral corticosteroids for systemic anti-inflammatory or immunosuppressive effect in conditions such as severe allergic reactions/allergic states, dermatologic diseases, endocrine disorders, selected gastrointestinal diseases, hematologic disorders, ophthalmic inflammatory diseases, respiratory diseases (including symptomatic sarcoidosis), and rheumatic disorders, when a depot (long-acting) corticosteroid effect is appropriate.
Adjunct/Combination Use
In many of the above systemic conditions, Methyl Prednisolone Acetate is used as an adjunct to, or as a substitute depot form of, standard disease-directed therapy (e.g., disease-modifying agents in rheumatoid arthritis) rather than as sole therapy for the underlying disease.
Note: Methyl Prednisolone Acetate is intended for intramuscular, intra-articular, soft-tissue, and intralesional use only. It must never be given intravenously or intrathecally/epidurally (see Contraindications).
Dosage & Administration of Methyl Prednisolone Acetate
Dosage and Administration of Methyl Prednisolone Acetate
Dosage of Methyl Prednisolone Acetate must be individualized according to the condition being treated, its severity, and the patient's response, using the lowest effective dose. General initial dosage ranges from 4 mg to 120 mg, depending on the indication.
| Indication/Route | Typical Dose |
|---|---|
| Large joints (e.g., knee, ankle, shoulder) — intra-articular | 20–80 mg per joint |
| Medium joints (e.g., elbow, wrist) — intra-articular | 10–40 mg per joint |
| Small joints (e.g., interphalangeal, metacarpophalangeal) — intra-articular | 4–10 mg per joint |
| Bursae, tendon sheaths, soft-tissue infiltration | 4–30 mg, depending on site |
| Intralesional (e.g., keloids, psoriatic plaques) | 20–60 mg, divided between injection sites as needed |
| Intramuscular (systemic effect) | Individualized; often 40–120 mg, repeated at intervals of 1–several weeks based on response |
Methyl Prednisolone Acetate suspension must be shaken well before withdrawal. It is for intramuscular, intra-articular, soft-tissue, or intralesional injection only — never intravenous, and never intrathecal/epidural (see Contraindications and Precautions). Repeated intra-articular injections into the same joint should be limited in frequency, as excessive use can accelerate cartilage damage.
Side Effects of Methyl Prednisolone Acetate
Side Effects of Methyl Prednisolone Acetate
Local (Injection-Related) Effects
- Injection-site atrophy, depigmentation, or subcutaneous fat atrophy, especially with repeated injection at the same site.
- Post-injection flare (transient increase in pain/inflammation).
- Joint infection — rare, but serious, if aseptic technique is not maintained during intra-articular injection.
Systemic Effects
- Hyperglycemia or worsening of diabetes control.
- Hypertension and fluid retention.
- Osteoporosis and increased fracture risk with repeated/prolonged systemic dosing.
- Adrenal suppression, particularly with repeated systemic dosing.
- Increased susceptibility to infections, and masking of signs of infection.
- Mood changes, insomnia, or psychiatric disturbances.
- Cushingoid features (weight gain, facial rounding) with repeated or prolonged use.
- Cataracts and increased intraocular pressure/glaucoma with prolonged use.
Contraindications of Methyl Prednisolone Acetate
Contraindications of Methyl Prednisolone Acetate
- Known hypersensitivity to Methyl Prednisolone Acetate or any component of the formulation.
- Systemic fungal infection (except when a localized intra-articular injection is being used for a non-infected joint under specific circumstances).
- Intra-articular injection of Methyl Prednisolone Acetate into a joint that is infected, or in the setting of active septic arthritis — joint infection must be excluded before injection.
- Intrathecal or epidural administration — Methyl Prednisolone Acetate is a specific, absolute contraindication for this route due to the risk of arachnoiditis and other serious neurologic events, including reports of death.
Frequently Asked Questions about Methyl Prednisolone Acetate
What is Methyl Prednisolone Acetate used for?
Methyl Prednisolone Acetate is an injectable, long-acting corticosteroid used for localized treatment of joint and soft-tissue inflammation (such as osteoarthritis flares, bursitis, and tendinitis) via intra-articular or soft-tissue injection, and for systemic anti-inflammatory or immunosuppressive therapy via intramuscular injection in conditions such as severe allergic reactions, certain autoimmune flares, and dermatologic diseases, as decided by your physician.
Can Methyl Prednisolone Acetate be given intravenously?
No. Methyl Prednisolone Acetate is a depot suspension intended only for intramuscular, intra-articular, soft-tissue, or intralesional injection. It must never be given intravenously and must never be given intrathecally or epidurally, because this route carries a risk of serious neurologic complications, including arachnoiditis.
How often can I receive a Methyl Prednisolone Acetate joint injection?
Repeated intra-articular injections of Methyl Prednisolone Acetate into the same joint should be limited in frequency and total number, as your physician will advise, because excessive repeated use can accelerate cartilage/joint damage. Follow your physician's specific re-treatment schedule.
Is Methyl Prednisolone Acetate safe during pregnancy?
Methyl Prednisolone Acetate should be used in pregnancy only if the potential benefit clearly justifies the potential risk to the fetus, as corticosteroids have shown effects on fetal development in animal studies. Always consult your physician before using Methyl Prednisolone Acetate if you are pregnant or planning pregnancy.
What side effects should I watch for after Methyl Prednisolone Acetate injection?
After Methyl Prednisolone Acetate injection, watch for injection-site changes (skin thinning, discoloration), signs of infection at the injection site (increasing pain, redness, swelling, fever), high blood sugar symptoms, and mood changes. Contact your physician promptly if these occur.
What should I do if too much Methyl Prednisolone Acetate is given?
If an overdose of Methyl Prednisolone Acetate is suspected, seek immediate medical attention or contact emergency services/poison control right away; do not attempt home treatment. Management is supportive and will be individualized by a physician.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.